Nab-paclitaxel plus tegafur gimeracil oteracil potassium capsule (S-1) as first-line treatment for advanced biliary tract adenocarcinoma: a phase 2 clinical trial

BACKGROUND: This study aimed to evaluate the efficacy and safety of a new combination of nab-paclitaxel plus tegafur gimeracil oteracil potassium capsule (S-1) for patients with advanced biliary tract carcinoma (BTC). METHODS: Patients were treated with nab-paclitaxel at a dose of 125 mg/m(2) on day...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wen, Sun, Yongkun, Jiang, Zhichao, Qu, Wang, Gong, Caifeng, Zhou, Aiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944545/
https://www.ncbi.nlm.nih.gov/pubmed/36860259
http://dx.doi.org/10.21037/hbsn-21-172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944545/
https://www.ncbi.nlm.nih.gov/pubmed/36860259
http://dx.doi.org/10.21037/hbsn-21-172

Ejemplares similares